Mesenchymal stem cells engineered to inhibit complement-mediated damage.
about
Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and SurvivalMesenchymal Stem Cells after Polytrauma: Actor and TargetComplement activation in the context of stem cells and tissue repairInternational Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.Regioselective synthesis and biological studies of novel 1-aryl-3, 5-bis (het) aryl pyrazole derivatives as potential antiproliferative agents.Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?Regenerative medicine: prospects for the treatment of inflammatory bowel disease.Painting factor H onto mesenchymal stem cells protects the cells from complement- and neutrophil-mediated damage.A genome-wide analysis of the gene expression profiles and alternative splicing events during the hypoxia-regulated osteogenic differentiation of human cartilage endplate-derived stem cells.Effects of Different Cell-Detaching Methods on the Viability and Cell Surface Antigen Expression of Synovial Mesenchymal Stem Cells.Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.Mammalian MSC from selected species: Features and applications.Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?
P2860
Q26744561-631D771D-D770-48AF-9670-E1CC8DA8599BQ26747314-0018E3E5-9D51-4D8D-8283-D48A70A5C8AEQ26782203-81842404-33A5-4BDB-9DDA-F4AC87621CA1Q30488740-50343B9E-5B61-4A81-8FA4-BB754B39C5E4Q32185870-0164919D-CEC1-4FE9-A094-09D14858D63DQ35240062-7E0EB53B-0CAC-41CD-AEC0-B5F78C95014AQ38133660-92528DBA-58DA-4093-B7B6-9ABE583872A8Q38407079-DBCB14AA-99AE-4ED8-8B24-960A1BE4AF64Q38665856-36C76E92-E67D-4228-94DF-FD2B59D37873Q38990353-2B6CEE86-FFFB-4DB3-B507-00073AFB2F3CQ44298061-4308EF25-DEE8-441B-A72B-9AB10CEB5156Q46307085-E705B9AD-DBA6-4633-9F55-8D393ECB2411Q50224283-D715769C-D1D1-4C02-9A20-ADC49B84DEC2
P2860
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@ast
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@en
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@nl
type
label
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@ast
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@en
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@nl
prefLabel
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@ast
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@en
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@nl
P2860
P50
P1433
P1476
Mesenchymal stem cells engineered to inhibit complement-mediated damage.
@en
P2093
Evan Colletti
Mariana Bego
P2860
P304
P356
10.1371/JOURNAL.PONE.0060461
P407
P577
2013-03-26T00:00:00Z